Profile of cardiac lipid metabolism in STZ-induced diabetic mice

被引:33
|
作者
Li, Wenjie [1 ]
Yao, Min [1 ]
Wang, Ruonan [1 ]
Shi, Yun [1 ]
Hou, Lianguo [1 ]
Hou, Ziyuan [2 ]
Lian, Kaoqi [1 ]
Zhang, Nan [1 ]
Wang, Yaqi [1 ]
Li, Weiwei [1 ]
Wang, Wei [1 ]
Jiang, Lingling [1 ]
机构
[1] Hebei Med Univ, China Adm Educ, Dept Biochem & Mol Biol, Key Lab Neurobiol & Vasc Biol, 361 Zhongshan East Rd, Shijiazhuang 050017, Hebei, Peoples R China
[2] Anyang Ctr Dis Control & Prevent, 01 Ziyou Rd, Anyang 455000, Henan, Peoples R China
来源
关键词
Diabetic myocardial disease; Lipotoxicity; Non-targeted metabolomics; Lipid metabolomics; FATTY-ACID-METABOLISM; UNCOUPLING PROTEINS; SHOTGUN LIPIDOMICS; OXIDATIVE STRESS; RAT-HEART; CARDIOMYOPATHY; MUSCLE; MYOCARDIUM; DISEASE; BRAIN;
D O I
10.1186/s12944-018-0872-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Lipotoxicity contributes to diabetic myocardial disease. In this study, we investigated the lipid species contributing to lipotoxicity and the relationship with peroxisomal beta-oxidation in the heart of diabetic mice. Methods: Male C57BL/6 mice were randomly divided into a Diabetic group (intraperitoneal injection of STZ) and a Control group (saline). Cardiac function indexes [ejection fraction (EF%) and fractional shortening (FS%)] were evaluated by echocardiography. Morphological changes in the myocardial tissues and mitochondria were assessed by electron microscopy following hematoxylin and eosin staining. Blood myocardial injury indexes and lipids were measured using an automatic biochemical analyzer. Cardiac ATP levels were analyzed using a commercially available kit. mRNA levels of glucose transporter 4 (GLUT4), fatty acid binding protein 3 (FABP3), palmitoyl transferase 1 (CPT-1), acyl-CoA oxidase 1 (AOX1), D-bifunctional protein (DBP), 3-ketoacyl-CoA thiolase A (THLA), uncoupling protein (UCP) 2 and UCP3 were investigated by quantitative reverse-transcription polymerase chain reaction. FABP3 protein expression was analyzed by Western blotting. Non-targeted metabolomics by LC-MS/MS was applied to evaluate profile of lipid metabolism in heart. Results: Compared with controls, EF% and FS% were significantly reduced in diabetic mice. Furthermore, blood myocardial injury indexes and lipids, as well as myocardial mitochondrial cristae fusion were significantly increased. In the diabetic heart, GLUT4 expression was decreased, while expression of FABP3, CPT-1, AOX1, DBP, THLA, UCP2 and UCP3 was increased, and ATP levels were reduced. In total, 113 lipids exhibited significant differential expression (FC > 2, P<0.05) between the two groups, with sphingolipid metabolism identified as the top-ranking affected canonical pathway. In the diabetic heart, long-chain hydroxyl-acylcarnitines (8/8) and acylcarnitines (6/11), triglycerides (2/5), and diacyglycerol (3/7) were upregulated, while very long-chain polyunsaturated fatty acids (PUFAs) (5/6) including eicosapentaenoate, docosahexaenoate, phosphocholine (11/19), lysophosphocholine (5/9), phosphoethanolamine (7/11), lysophosphoethanolamine (7/10), phosphatidylglycerol (6/8), phosphoserine (6/8), phosphatidylinositol (2/2), phosphatidic acid (1/1), lysophosphatidic acid (1/1) and sphingomyelin (6/6) were downregulated. Conclusions: Our data suggest that the increase in toxic lipid species and decreased in PUFAs undergoing peroxisomal beta-oxidation, combined with the reduction in phospholipids cause mitochondrial injury and subsequent uncoupling of phosphorylation and ATP deficiency; thereby leading to diabetic heart dysfunction.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Profile of cardiac lipid metabolism in STZ-induced diabetic mice
    Wenjie Li
    Min Yao
    Ruonan Wang
    Yun Shi
    Lianguo Hou
    Ziyuan Hou
    Kaoqi Lian
    Nan Zhang
    Yaqi Wang
    Weiwei Li
    Wei Wang
    Lingling Jiang
    [J]. Lipids in Health and Disease, 17
  • [2] Metformin ameliorates insulitis in STZ-induced diabetic mice
    Jiang, Guo-Jun
    Han, Xue
    Tao, Yu-Long
    Deng, Ya-Ping
    Yu, Jia-Wen
    Cai, Jian
    Ren, Guo-Fei
    Sun, Yuan-Nan
    [J]. PEERJ, 2017, 5
  • [3] Chrysin improves diabetic nephropathy by regulating the AMPK-mediated lipid metabolism in HFD/STZ-induced DN mice
    Zhou, Yingjun
    Tao, Heng
    Xu, Nuo
    Zhou, Shichun
    Peng, Yuke
    Zhu, Jianxiang
    Liu, Shaowei
    Chang, Yaning
    [J]. JOURNAL OF FOOD BIOCHEMISTRY, 2022, 46 (12)
  • [4] Protective effects of epoxypukalide on pancreatic β-cells and glucose metabolism in STZ-induced diabetic mice
    Lopez-Acosta, Jose F.
    Villa-Perez, Pablo
    Fernandez-Diaz, Cristina M.
    de Luis Roman, Daniel
    Diaz-Marrero, Ana R.
    Cueto, Mercedes
    Perdomo, German
    Cozar-Castellano, Irene
    [J]. ISLETS, 2015, 7 (02)
  • [5] Fumaria parviflora improves liver damage and lipid profile changes in STZ-induced diabetic rats
    Kooshki, Fateme
    Niazkar, Hamid Reza
    Shirazi, Shabnam
    Azar, Vahid Asghari
    Moghimian, Maryam
    Karimi, Arash
    [J]. PHYSIOLOGY AND PHARMACOLOGY, 2020, 24 (03): : 221 - 229
  • [6] MARK4 aggravates cardiac dysfunction in mice with STZ-induced diabetic cardiomyopathy by regulating ACSL4-mediated myocardial lipid metabolism
    Wu, Yi
    Zhang, Jingqi
    Wang, Weiyi
    Wu, Dongdong
    Kang, Yang
    Fu, Lu
    [J]. SCIENTIFIC REPORTS, 2024, 14 (01):
  • [7] Effects of benazepril on cardiac fibrosis in STZ-induced diabetic rats
    Li, Qian
    Wang, Yi
    Sun, Shu-zhen
    Tian, Yong-jie
    Liu, Ming-hua
    [J]. ACTA CARDIOLOGICA, 2010, 65 (04) : 431 - 439
  • [8] CHYLOMICRON AND CHYLOMICRON REMNANT METABOLISM IN STZ-INDUCED DIABETIC RATS
    STAPRANS, I
    PAN, XM
    RAPP, JH
    FEINGOLD, KR
    [J]. DIABETES, 1992, 41 (03) : 325 - 433
  • [9] ALTERATIONS IN CARDIAC PARASYMPATHETIC INDEXES IN STZ-INDUCED DIABETIC RATS
    LUND, DD
    SUBIETA, AR
    PARDINI, BJ
    CHANG, KSK
    [J]. DIABETES, 1992, 41 (02) : 160 - 166
  • [10] Interaction of insulin with prokinetic drugs in STZ-induced diabetic mice
    Mohamed A Fouad Shalaby
    Hekma A Abd El Latif
    Mostafa E El Sayed
    [J]. World Journal of Gastrointestinal Pharmacology and Therapeutics, 2013, (02) : 28 - 38